Immune T cells swarm to tumours by following a chemical gradient left by other cancer-killing T cells, a pre-clinical study by EMBL Australia group leader Dr Maté Biro and his team has shown.

EMBL Australia group leader Dr Harald Janovjak was recently awarded a prestigious ARC Future Fellowship to develop innovative genomic tools.

News this quarter:

• Perspectives on COVID-19 from the European experience
• Keratins determine cell fate in early mammalian development
• Two group leaders awarded ARC Future Fellowships
• #2020EAPS: Register for our online postgraduate symposium
• Group leader spearheads novel method of enhancing regenerative activity
• Using stem cells to treat muscle injury and wasting disorders
• Get to Know: Associate Professor Max Cryle

And more:

• Job opportunities
• Student opportunities & upcoming events
• Recent publications

Research by EMBL Australia alumnus Dr Nico Plachta and group leader Dr Maté Biro, and published in Nature, has led to a fundamental discovery that advances our understanding of how mammals develop in the earliest stages after fertilisation.

Professor Ewan Birney, the Deputy Director General of EMBL and Director of EMBL-EBI, is a participant in the Oxford trial for a COVID-19 vaccine and shared his views on the global coronavirus pandemic with us.

Associate Professor Max Cryle is an EMBL Australia Group Leader, based at the Monash Biomedicine Discovery Institute. 

EMBL Australia group leader A/Prof Mikaël Martino and Victorian node head Prof Peter Currie will use a grant of more than $820,000 from the Medical Research Future Fund's Stem Cell Therapies Mission to improve the lives of those with muscular dystrophies & myopathies.

Two EMBL Australia group leaders have been awarded close to $2 million in funding for their innovative projects under the Australian Research Council’s Future Fellowships scheme.

New research from an EMBL Australia group leader outlines a novel method of enhancing regenerative activity, with clinical implications on improving the effectiveness of growth factor-based therapies.

In 2019, the EMBL Australia Partner Laboratory Network continued to expand, with the addition of three new research groups. We trained hundreds of PhD students in the life sciences through various student programs, strengthened international linkages and our researchers were awarded a number of highly competitive grants, made innovative discoveries and published many high-impact papers.